earnings
XF
NASDAQ · XFOR
X4 Pharmaceuticals, Inc.
Healthcare · Biotechnology
$3.40
Down-$0.20 (-5.56%)
Updated Sep 11, 2026, 10:55 AM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 44.21M
- P/E ratio
- -0.28
- Dividend yield
- 0.00%
- 52-week range
- $2.80 – $4.83
- Volume
- 2.57M
- Avg. volume
- 894.59K
Price performance
XFOR price history
1M range · 20 trading sessions · Daily adjusted prices
XFOR closed at $3.40 after 20 trading sessions, down 20.75% for the selected period.
- Last close
- $3.40
- Period change
- -20.75%
- Period low
- $3.40
- Period high
- $4.30
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $3.60 | $3.675 | $3.31 | $3.40 | 2.57M |
| Sep 9, 2026 | $3.50 | $3.67 | $3.45 | $3.60 | 1.4M |
| Sep 8, 2026 | $4.00 | $4.1254 | $3.19 | $3.505 | 2.32M |
| Sep 4, 2026 | $4.01 | $4.08 | $4.00 | $4.04 | 168.16K |
| Sep 3, 2026 | $4.06 | $4.0691 | $3.99 | $4.04 | 409.44K |
| Sep 2, 2026 | $4.10 | $4.17 | $4.015 | $4.04 | 360.96K |
| Sep 1, 2026 | $3.97 | $4.11 | $3.97 | $4.07 | 203.87K |
| Aug 31, 2026 | $4.02 | $4.10 | $4.00 | $4.04 | 245.89K |
| Aug 28, 2026 | $4.22 | $4.23 | $4.00 | $4.04 | 356.38K |
| Aug 27, 2026 | $4.18 | $4.39 | $4.145 | $4.23 | 597.24K |
| Aug 26, 2026 | $4.16 | $4.23 | $4.075 | $4.17 | 707.14K |
| Aug 25, 2026 | $4.05 | $4.18 | $3.995 | $4.16 | 390.76K |
| Aug 24, 2026 | $4.03 | $4.095 | $3.94 | $4.05 | 299.17K |
| Aug 21, 2026 | $4.05 | $4.175 | $4.005 | $4.04 | 1.22M |
| Aug 20, 2026 | $4.12 | $4.22 | $3.99 | $4.03 | 561.21K |
| Aug 19, 2026 | $4.25 | $4.35 | $4.14 | $4.16 | 406.05K |
| Aug 18, 2026 | $4.27 | $4.32 | $4.145 | $4.21 | 362.09K |
| Aug 17, 2026 | $4.20 | $4.335 | $4.13 | $4.30 | 1.1M |
| Aug 14, 2026 | $4.26 | $4.33 | $4.05 | $4.22 | 840.93K |
| Aug 13, 2026 | $4.28 | $4.455 | $4.19 | $4.29 | 1.13M |
Latest XFOR news
The latest Smart Investors Daily articles mentioning XFOR.
Stock researchMarket Activity · Short Interest
Loading stock research…